Items where Author is "El-Sherbiny, Y"

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 10.

Journal article

ROBINSON, J.I., MD YUSOF, M.Y., DAVIES, V., WILD, D., MORGAN, M., TAYLOR, J.C., EL-SHERBINY, Y., MORRIS, D.L., LIU, L., RAWSTRON, A.C., BUCH, M.H., PLANT, D., CORDELL, H.J., ISAACS, J.D., BRUCE, I.N., EMERY, P., BARTON, A., VYSE, T.J., BARRETT, H., VITAL, E.M. and MORGAN, A.W., 2022. Comprehensive genetic and functional analyses of Fc gamma receptors influence on response to rituximab therapy for autoimmunity. EBioMedicine. ISSN 2352-3964 (Forthcoming)

EL-JAWHARI, J.J., EL-SHERBINY, Y., MCGONAGLE, D. and JONES, E., 2021. Multipotent mesenchymal stromal cells in rheumatoid arthritis and systemic lupus erythematosus; from a leading role in pathogenesis to potential therapeutic saviors? Frontiers in Immunology, 12: 643170. ISSN 1664-3224

ROSS, R., CORINALDESI, C., MIGNECO, G., CARR, I., ANTANAVICIUTE, A., WASSON, C., CARRIERO, A., DISTLER, J., HOLMES, S., EL-SHERBINY, Y., MCKIMMIE, C. and DEL GALDO, F., 2021. Targeting human plasmacytoid dendritic cells through BDCA2 prevents skin inflammation and fibrosis in a novel xenotransplant mouse model of scleroderma. Annals of the Rheumatic Diseases. ISSN 0003-4967

EL-JAWHARI, J.J., KLEFTOURIS, G., EL-SHERBINY, Y., SALEEB, H., WEST, R.M., JONES, E. and GIANNOUDIS, P.V., 2019. Defective proliferation and osteogenic potential with altered immunoregulatory phenotype of native bone marrow-multipotential stromal cells in atrophic fracture non-union. Scientific Reports, 9 (1): 17340. ISSN 2045-2322

SELEEM, A.K., AZIZ EL REFAEEY, A., SHAALAN, D., EL-SHERBINY, Y. and BADAWY, A., 2014. Superoxide dismutase in polycystic ovary syndrome patients undergoing intracytoplasmic sperm injection. Journal of Assisted Reproduction and Genetics, 31 (4), pp. 499-504. ISSN 1058-0468

DAS, S., VITAL, E.M., HORTON, S., BRYER, D., EL-SHERBINY, Y., RAWSTRON, A.C., PONCHEL, F., EMERY, P. and BUCH, M.H., 2014. Abatacept or tocilizumab after rituximab in rheumatoid arthritis? An exploratory study suggests non-response to rituximab is associated with persistently high IL-6 and better clinical response to IL-6 blocking therapy. Annals of the Rheumatic Diseases, 73 (5), pp. 909-912. ISSN 0003-4967

PONCHEL, F., GOËB, V., PARMAR, R., EL-SHERBINY, Y., BOISSINOT, M., EL JAWHARI, J., BURSKA, A., VITAL, E.M., HARRISON, S., CONAGHAN, P.G., HENSOR, E. and EMERY, P., 2014. An immunological biomarker to predict MTX response in early RA. Annals of the Rheumatic Diseases, 73 (11), pp. 2047-2053. ISSN 0003-4967

Chapter in book

MD YUSOF, M.Y., ROBINSON, J., DAVIES, V., WILD, D., MORGAN, M., TAYLOR, J., EL-SHERBINY, Y., MORRIS, D., LIU, L., RAWSTRON, A., BUCH, M.H., PLANT, D., CORDELL, H., ISAACS, J., BRUCE, I.N., EMERY, P., BARTON, A., VYSE, T., BARRETT, J., VITAL, E. and MORGAN, A., 2022. OP0190 Comprehensive genetic and functional analyses of fc gamma receptors explain response to rituximab therapy for autoimmune rheumatic diseases. In: Scientific Abstracts oral presentations. Modern technology for precision medicine. Annals of the Rheumatic Diseases, 81 . BMJ Publishing Group, p. 126.

KOUROUPIS, D., WANG, X.N., EL-SHERBINY, Y., MCGONAGLE, D. and JONES, E., 2017. The safety of non-expanded multipotential stromal cell therapies. In: P. VAN PHAM and A. ROSEMANN, eds., Safety, ethics and regulations. Stem cells in clinical applications (SCCA) . Cham: Springer, pp. 91-118. ISBN 9783319591643

Patent/Published patent application

MCGOANGLE, D., JONES, E., EL-SHERBINY, Y. and MOSELEY, T., 2017. Immunomodulation with implantation of cellular allograft bone into a non-bony site. 1202617.

This list was generated on Mon Jan 30 08:38:49 2023 UTC.